Hypertrophic cardiomyopathy: The pathological features and the molecular pathogenesis (multiple letters) [4]
dc.contributor.author | Davutoǧlu V. | |
dc.contributor.author | Çam F.S. | |
dc.contributor.author | Güray M. | |
dc.date.accessioned | 2024-07-22T08:24:03Z | |
dc.date.available | 2024-07-22T08:24:03Z | |
dc.date.issued | 2005 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.issn | 13028723 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19796 | |
dc.language.iso | English | |
dc.subject | Cardiology | |
dc.subject | Cardiomyopathy, Hypertrophic | |
dc.subject | Humans | |
dc.subject | Peer Review | |
dc.subject | Periodicals | |
dc.subject | alanine | |
dc.subject | aspartic acid | |
dc.subject | cysteine | |
dc.subject | glutamic acid | |
dc.subject | leucine | |
dc.subject | methionine | |
dc.subject | myosin binding protein C | |
dc.subject | myosin heavy chain | |
dc.subject | proline | |
dc.subject | serine | |
dc.subject | valine | |
dc.subject | angina pectoris | |
dc.subject | clinical feature | |
dc.subject | competence | |
dc.subject | decision making | |
dc.subject | disease severity | |
dc.subject | dyspnea | |
dc.subject | echocardiography | |
dc.subject | environmental factor | |
dc.subject | family study | |
dc.subject | gene frequency | |
dc.subject | gene mutation | |
dc.subject | genetic analysis | |
dc.subject | genetic association | |
dc.subject | genetic heterogeneity | |
dc.subject | genotype phenotype correlation | |
dc.subject | heart ventricle arrhythmia | |
dc.subject | heredity | |
dc.subject | high risk patient | |
dc.subject | human | |
dc.subject | hypertrophic cardiomyopathy | |
dc.subject | information processing | |
dc.subject | letter | |
dc.subject | medical literature | |
dc.subject | medical specialist | |
dc.subject | MEDLINE | |
dc.subject | methodology | |
dc.subject | mutational analysis | |
dc.subject | pathogenesis | |
dc.subject | peer review | |
dc.subject | population genetics | |
dc.subject | prediction | |
dc.subject | prevalence | |
dc.subject | risk assessment | |
dc.subject | risk factor | |
dc.subject | sensitivity and specificity | |
dc.subject | sudden death | |
dc.subject | symptom | |
dc.subject | syncope | |
dc.subject | Turkey (republic) | |
dc.subject | United States | |
dc.title | Hypertrophic cardiomyopathy: The pathological features and the molecular pathogenesis (multiple letters) [4] | |
dc.type | Letter |